A series of death cases at detox centers has raised questions about safety and oversight in the industry. The Substance Abuse and Mental Health Services Administration reports over 17,800 substance use treatment facilities operating across the United States, with private equity firms holding stakes in roughly 7% of them.

Oversight and Safety Concerns

Many families assume that detox and residential treatment centers operate under the same strict rules as hospitals, but the reality is far less standardized. State licensing and accreditation requirements vary, and medical supervision rules depend on how a state classifies the facility.

In California, a wave of wrongful death cases has been filed against detox and residential facilities, with families alleging that promised 24/7 medical supervision did not exist. One case involves 21-year-old Issac Charlton, who died of a combined fentanyl and diazepam overdose after a staff member allegedly offered to supply him with controlled substances.

Financial Incentives and Care Models

Private treatment programs often run on a per-day reimbursement model, where insurance pays a set rate for every night a patient occupies a bed. This can create pressure to keep beds filled, leading to concerns about the quality of care and patient supervision.

Families are advised to research facilities thoroughly and ask questions about staffing, medical supervision, and incident records before making a decision.

Original reporting: KTBS 3 (Shreveport) — read the source article.